These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24716639)

  • 41. [Not Available].
    Bruggmann P
    Praxis (Bern 1994); 2016 Jul; 105(15):885-9. PubMed ID: 27463274
    [No Abstract]   [Full Text] [Related]  

  • 42. Impact of a clinical nurse specialist on the treatment of chronic hepatitis C.
    Shutt JD; Robathan J; Vyas SK
    Br J Nurs; 2008 May 8-21; 17(9):572-5. PubMed ID: 18562991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Public Health Clinic-Based Hepatitis C Treatment.
    Rosecrans AM; Cheedalla A; Rives ST; Scotti LA; Harris RE; Greenbaum AH; Irvin RR; Ntiri-Reid BA; Brown HT; Alston KE; Smith JA; Page KR; Falade-Nwulia OO
    Am J Prev Med; 2020 Sep; 59(3):420-427. PubMed ID: 32430222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.
    Sagan SM; Dupont B; Grebely J; Krajden M; MacParland SA; Raven JF; Saeed S; Feld JJ; Tyrrell DL; Wilson JA
    Can J Gastroenterol Hepatol; 2016; 2016():5743521. PubMed ID: 27446849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving access to treatment for patients with chronic hepatitis C through outreach.
    Elsharkawy AM; Miller C; Hearn A; Buerstedde G; Price A; McPherson S
    Frontline Gastroenterol; 2013 Apr; 4(2):125-129. PubMed ID: 28839713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of the ECHO
    Marciano S; Haddad L; Plazzotta F; Mauro E; Terraza S; Arora S; Thornton K; Ríos B; García Dans C; Ratusnu N; Calanni L; Allevato J; Sirotinsky ME; Pedrosa M; Gadano A
    J Med Virol; 2017 Apr; 89(4):660-664. PubMed ID: 27551942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiviral treatment for chronic hepatitis C: reasons for non-treatment in a Northern Indian center.
    Sood A; Midha V; Sood N; Bansal M
    Indian J Gastroenterol; 2006; 25(6):319-20. PubMed ID: 17264442
    [No Abstract]   [Full Text] [Related]  

  • 48. Hepatitis C Treatment Delivery Mandates Optimizing Available Health Care Human Resources: A Case for Task Shifting.
    Jayasekera CR; Arora S; Ahmed A
    JAMA; 2016 May; 315(18):1947-8. PubMed ID: 27163981
    [No Abstract]   [Full Text] [Related]  

  • 49. Intelligent MONitoring System for antiviral pharmacotherapy in patients with chronic hepatitis C (SiMON-VC).
    Margusino-Framiñán L; Cid-Silva P; Mena-de-Cea Á; Sanclaudio-Luhía AI; Castro-Castro JA; Vázquez-González G; Martín-Herranz I
    Farm Hosp; 2017 Jan; 41(n01):68-88. PubMed ID: 28045653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transforming treatment for hepatitis C.
    The Lancet
    Lancet; 2018 Jul; 392(10144):254. PubMed ID: 30064639
    [No Abstract]   [Full Text] [Related]  

  • 51. Gastroenterologists can enhance hepatitis C screening by testing individuals referred for colorectal cancer screening.
    Lattimer L; Kumar A; Sekaran A; Borum M
    J Viral Hepat; 2014 Oct; 21(10):e135. PubMed ID: 25268592
    [No Abstract]   [Full Text] [Related]  

  • 52. A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy.
    Lutchman G; Kim WR
    Hepatology; 2015 May; 61(5):1455-8. PubMed ID: 25614010
    [No Abstract]   [Full Text] [Related]  

  • 53. Case studies. Scots lead the way.
    Health Serv J; 2014 Aug; 124(6410):suppl 10-2. PubMed ID: 25314755
    [No Abstract]   [Full Text] [Related]  

  • 54. Predictors of Voice Therapy Attendance in an Interdisciplinary Care Model.
    Weston ZM; Gochman G; Schneider SL
    J Voice; 2023 Dec; ():. PubMed ID: 38044170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The complex self perceptions and relationships of patients who attended free clinics affected their attendance and ability to benefit from care.
    Larson P
    Evid Based Nurs; 2006 Apr; 9(2):61. PubMed ID: 16622937
    [No Abstract]   [Full Text] [Related]  

  • 56. Rapid Initiation of Hepatitis C Virus Treatment.
    Lichtenstein GR
    Gastroenterol Hepatol (N Y); 2022 Nov; 18(11):615. PubMed ID: 36866027
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatitis C: Impact of ethnicity on hepatitis C treatment outcomes.
    Franks I
    Nat Rev Gastroenterol Hepatol; 2011 Jun; 8(6):299. PubMed ID: 21522114
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis Requires Public Health Action.
    Binns C; Low WY
    Asia Pac J Public Health; 2017 Jul; 29(5):348-350. PubMed ID: 28719792
    [No Abstract]   [Full Text] [Related]  

  • 59. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
    Hamill V; Wong S; Benselin J; Krajden M; Hayes PC; Mutimer D; Yu A; Dillon JF; Gelson W; Velásquez García HA; Yeung A; Johnson P; Barclay ST; Alvarez M; Toyoda H; Agarwal K; Fraser A; Bartlett S; Aldersley M; Bathgate A; Binka M; Richardson P; Morling JR; Ryder SD; MacDonald D; Hutchinson S; Barnes E; Guha IN; Irving WL; Janjua NZ; Innes H
    BMJ; 2023 Aug; 382():e074001. PubMed ID: 37532284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection.
    Miller-Archie SA; Walters SC; Bocour A; Moore MS; Wiewel E; Singh T; Lim S
    J Infect Dis; 2022 Oct; 226(Suppl 3):S363-S371. PubMed ID: 36208165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.